Gujarat Terce Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 10.95 | 12.41 | 12.75 |
| Operating Expense | 10.87 | 11.27 | 11.59 |
| Net Profit | -0.04 | -3.39 | 1.01 |
| Net Profit Margin | -0.37 | -27.32 | 7.92 |
| Earning Per Share | -0.06 | -4.57 | 1.36 |
| EBIDTA | 0.11 | 0.36 | 1.19 |
| Effective Tax Rate | TBA | 314.04 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 10.95 |
| Operating Expense | 10.87 |
| Net Profit | -0.04 |
| Net Profit Margin | -0.37 |
| Earning Per Share | -0.06 |
| EBIDTA | 0.11 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 50.20 | 47.97 | 46.78 |
| Operating Expenses Annual | 46.31 | 46.71 | 48.95 |
| Operating Profit Annual | 4.19 | 1.59 | -1.81 |
| Interest Annual | 0.42 | 0.68 | 0.72 |
| Depreciation | 0.38 | 0.37 | 0.36 |
| Net Profit Annual | -0.98 | 0.24 | -1.67 |
| Tax Annual | 4.37 | 0.30 | -1.22 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 50.20 |
| Operating Expenses Annual | 46.31 |
| Operating Profit Annual | 4.19 |
| Interest Annual | 0.42 |
| Depreciation | 0.38 |
| Net Profit Annual | -0.98 |
| Tax Annual | 4.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.09 | 2.03 | 1.51 |
| Cash Flow from Operations | 3.06 | 2.60 | 0.03 |
| Cash Flow from Investing | 0.46 | -0.46 | 0.62 |
| Cash Flow from Financing | -2.83 | -4.08 | -0.12 |
| Cash Flow at the End | 0.78 | 0.09 | 2.03 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | 3.06 |
| Cash Flow from Investing | 0.46 |
| Cash Flow from Financing | -2.83 |
| Cash Flow at the End | 0.78 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 8.37 | 3.31 | -3.87 |
| PBIT Margin (%) | 7.61 | 2.54 | -4.64 |
| PBT Margin (%) | -10.46 | -1.19 | 1.79 |
| Net PROFIT Margin (%) | -1.95 | 0.50 | -3.57 |
| Return On Networth / Equity (%) | TBA | 2.96 | TBA |
| Return On Networth /Employed (%) | TBA | 7.17 | TBA |
| Return On Assets (%) | -7.87 | 1.51 | -9.21 |
| Total Debt / Equity (X) | 0.35 | 0.80 | 0.91 |
| Asset Turnover Ratio (%) | 4.03 | 3.02 | 2.58 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 8.37 |
| PBIT Margin (%) | 7.61 |
| PBT Margin (%) | -10.46 |
| Net PROFIT Margin (%) | -1.95 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -7.87 |
| Total Debt / Equity (X) | 0.35 |
| Asset Turnover Ratio (%) | 4.03 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 3.65 | 3.69 | 3.99 |
| Total Current Assets Annual | 12.02 | 11.22 | 16.05 |
| Non Current Assets Annual | 10.80 | 12.05 | 12.48 |
| Total Shareholders Funds Annual | 6.48 | 7.11 | 6.86 |
| Total Assets Annual | 22.83 | 23.27 | 28.53 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 3.65 |
| Total Current Assets Annual | 12.02 |
| Non Current Assets Annual | 10.80 |
| Total Shareholders Funds Annual | 6.48 |
| Total Assets Annual | 22.83 |
EPS (INR)
Expected
0.61
Reported
0.61
Surprise
0.00%
Jun 2021
EPS beaten by 0.00%
Sep 2020
EPS beaten by 0.00%
Jun 2020
EPS beaten by 0.00%
